Tetra Bio-Pharma (TSX: TBP) (OTC: TBPMF) CEO Guy Chamberland, Ph.D., discusses cannabinoid-based drug pipeline.

October 17, 2018 admin CEO Interview, Healthcare Comments Off on Tetra Bio-Pharma (TSX: TBP) (OTC: TBPMF) CEO Guy Chamberland, Ph.D., discusses cannabinoid-based drug pipeline.

tetra logo

 

Get our FREE Newsletter! Discover Stocks with +1,000% Upside Potential!
Join over 100,000 investors and business leaders worldwide. Discover the Next Super Stock before the rest of the crowd.
Your privacy is our priority. Your email address will never be sold or shared with anyone else.

 

 

Guy Chamberland

 

 

 

 

 

Tetra Bio-Pharma (TSX: TBP) (OTC: TBPMF) CEO Guy Chamberland, Ph.D., shares update on Tetra’s Cannabinoid-based drug pipeline as opioid alternative.

Investor Presentation Deck
Tetra Investor Presentation




Related Articles

Newsmakers

Yield Growth (OTC: BOSQF) Announces USA Luxury and Wellness Retailers to Carry Urban Juve Hemp Products

May 1, 2019 admin Newsmakers Comments Off on Yield Growth (OTC: BOSQF) Announces USA Luxury and Wellness Retailers to Carry Urban Juve Hemp Products

VANCOUVER, British Columbia, May 01, 2019 — The Yield Growth Corp. (CSE:BOSS) (OTC:BOSQF) (Frankfurt: YG3) subsidiary Urban Juve announces new U.S.A. retail contracts with luxury spa, wellness and specialty shops to sell its extensive, unisex range of […]

Newsmakers

Yield Growth Application for new INCI name granted for Yield Growth’s (OTC: BOSQF) Cannabis Sativa Hemp Root Oil made with Patent Pending Technology

April 23, 2019 admin Newsmakers Comments Off on Yield Growth Application for new INCI name granted for Yield Growth’s (OTC: BOSQF) Cannabis Sativa Hemp Root Oil made with Patent Pending Technology

VANCOUVER, British Columbia, April 23, 2019  — The Yield Growth Corp. (CSE :BOSS) (OTC: BOSQF) (Frankfurt: YG3) announces it has been successful in its application to obtain an International Nomenclature Cosmetic Ingredient (INCI) name for its novel […]

CEO Interview

MGC Pharmaceuticals, LTD. (ASX: MXC) (OTC: MGCLF) Cannabis-based pharmaceuticals for major markets (revenue positive)

May 29, 2019 admin CEO Interview, Healthcare Comments Off on MGC Pharmaceuticals, LTD. (ASX: MXC) (OTC: MGCLF) Cannabis-based pharmaceuticals for major markets (revenue positive)

  Get our FREE Newsletter! Discover Stocks with +1,000% Upside Potential! Thank you for subscribing. Something went wrong. Join over 100,000 investors and business leaders worldwide. Discover the Next Super Stock before the rest of […]